Recent developments in cannabinoid ligands
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 77 (14) , 1767-1798
- https://doi.org/10.1016/j.lfs.2005.05.020
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Pharmacophoric Requirements for the Cannabinoid Side Chain. Probing the Cannabinoid Receptor Subsite at C1‘Journal of Medicinal Chemistry, 2003
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Novel conformationally restricted tetracyclic analogs of Δ8-tetrahydrocannabinolBioorganic & Medicinal Chemistry Letters, 1999
- The CB1Cannabinoid Receptor in the BrainNeurobiology of Disease, 1998
- Importance of the C-1 Substituent in Classical Cannabinoids to CB2 Receptor Selectivity: Synthesis and Characterization of a Series of O,2-Propano-Δ8-tetrahydrocannabinol AnalogsJournal of Medicinal Chemistry, 1997
- A novel class of potent tetrahydrocannabinols (THCS): 2′-YNE-Δ8- and Δ9-THCSLife Sciences, 1995
- Classical/non-classical cannabinoid hybrids; Stereochemical requirements for the southern hydroxyalkyl chainLife Sciences, 1995
- Variation of the alkyl side chain in Δ8-THCLife Sciences, 1995
- Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonistLife Sciences, 1995
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964